US agency warns against morcellation in hysterectomies and myomectomiesBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2872 (Published 22 April 2014) Cite this as: BMJ 2014;348:g2872
- Michael McCarthy
- 1Seattle, USA
The US Food and Drug Administration (FDA) issued a safety communication on 17 April urging doctors not to use laparoscopic power morcellation for hysterectomies or removal of uterine fibroids over concerns that the technique may spread uterine sarcomas beyond the uterus.1
These procedures use a device with rapidly spinning blades to cut the uterine tissue into fragments so that it can be removed through a small incision. The term comes from the French morceler, to break into pieces.
However, according to a new FDA analysis, about 1 in 350 women having a hysterectomy or myomectomy for …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.